Skip to main content
. 2021 Mar 2;6(2):100065. doi: 10.1016/j.esmoop.2021.100065

Figure 1.

Figure 1

Hematologic (A) and organ response rates according to the 2012 (B) and proposed 2018 (C) criteria. CR, complete response; Dara/dex, daratumumab and dexamethasone; ORR, overall response rate; PR, partial response; VGPR, very good partial response.